MedTrace Logo

Renal Denervation in Patients With Refractory Hypertension

NCT00753285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2014-11-10

No results posted yet for this study

Summary

The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of refractory hypertension.

Conditions

Interventions

DEVICE

Renal Denervation

Sponsors & Collaborators

  • Medtronic Vascular

    lead INDUSTRY

Principal Investigators

  • Henry Krum, PhD · Monash University and the Alfred Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00753285 on ClinicalTrials.gov